Simcere Pharma sells stake in Shanghai Celgen Bio-Pharmaceutical for about $48 million
By The Associated Press | Associated Press – Tue, Jan 22, 2013 8:49 AM EST
Simcere Pharmaceutical Group has agreed to sell its stake in Shanghai Celgen Bio-Pharmaceutical Co. Ltd. for about 302 million yuan ($48.1 million).
The Chinese drug developer said Tuesday it entered into a share transfer agreement with Devont Asset Management Ltd. on Jan. 15 to sell its roughly 35 percent equity interest in Shanghai, which it acquired in 2009.
After the deal is completed, Simcere will no longer hold an equity interest in the company.
Simcere makes and sells pharmaceuticals in China, and focuses on the treatment of diseases that have high incidence or mortality rates like cancer, strokes or cardiovascular diseases.
Recent SCR News
- /C O R R E C T I O N from Source -- Strathcona Resources Ltd./ • PR Newswire (US) • 04/15/2024 10:35:00 PM
- Strathcona Announces Q1 2024 Conference Call • PR Newswire (Canada) • 04/15/2024 09:51:00 PM
- Strathcona Announces Q1 2024 Conference Call • PR Newswire (US) • 04/15/2024 09:51:00 PM
- Strathcona Resources Ltd. Reports Fourth Quarter and Full Year 2023 Financial and Operating Results • PR Newswire (Canada) • 03/26/2024 11:47:00 PM
- Strathcona Resources Ltd. Reports Fourth Quarter and Full Year 2023 Financial and Operating Results • PR Newswire (US) • 03/26/2024 11:47:00 PM
- Strathcona Resources Ltd. Reports Year End 2023 Reserves • PR Newswire (US) • 03/12/2024 02:07:00 AM
- Strathcona Resources Ltd. Reports Year End 2023 Reserves • PR Newswire (Canada) • 03/12/2024 02:07:00 AM
- Strathcona Announces Q4 2023 Conference Call • PR Newswire (US) • 02/08/2024 10:18:00 PM
- Strathcona Announces Q4 2023 Conference Call • PR Newswire (Canada) • 02/08/2024 10:18:00 PM
- Strathcona Resources Ltd. Reports Third Quarter 2023 Results and Announces 2023 and 2024 Guidance • PR Newswire (US) • 11/13/2023 11:30:00 PM
- Strathcona Resources Ltd. Reports Third Quarter 2023 Results and Announces 2023 and 2024 Guidance • PR Newswire (Canada) • 11/13/2023 11:30:00 PM
- Strathcona Resources Ltd. Announces Q3 2023 Conference Call • PR Newswire (US) • 10/19/2023 08:34:00 PM
- Strathcona Resources Ltd. Announces Q3 2023 Conference Call • PR Newswire (Canada) • 10/19/2023 08:34:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM